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Background/aim: Dapagliflozin (DAPA), sodium-glucose cotransporter 2 (SGLT2) inhibitor, is an insulin-independent antidiabetic
drug used to control hyperglycaemia by promoting glucose excretion from the kidney. Its adverse effects include orthostatic hypotension,
dehydration and urinary tract and genital infections caused by glycosuria. DAPA is subjected to constant additional monitoring, as drugrelated adverse reactions are frequently updated in line with the results of case studies, clinical trials and in vivo studies. Some antidiabetic
drugs have shown potential harmful effects on the male reproductive system; however, the effects of DAPA have not been sufficiently studied
in this capacity. Aiming to fill this gap in the literature, the present work investigates the toxic effects of DAPA on the male reproductive
system.
Materials and methods: Diabetes was induced using streptozotocin (STZ) in adult male Sprague-Dawley (SD) rats. DAPA (10 mg/kg)
was administered by gavage to the diabetic rats over 28 days, after which the animals were sacrificed. The biochemical, morphological and
histological examinations were performed on testicle, sperm and plasma samples.
Results: As a result of this study, we observed reproductive system damage in the form of induction of apoptosis in the seminiferous tubules,
changes in testis and sperm parameters and oxidative damage, alongside the development of diabetes in test animals. With the exception
of sperm morphological damage, the changes observed in diabetic animals treated with DAPA were similar to those of the control group.
Improvements were observed in histological, hormonal and proliferative parameters in the DAPA group compared to the DC group.
Conclusion: Even if DAPA is found to have antioxidant effects, it may raise abnormal sperm counts through a mechanism completely
independent of these effects and thus may not have a significant toxic effect on the male reproductive system.
Key words: Type-2 diabetes, dapagliflozin, male reproductive system, oxidative damage

1. Introduction
Since the 10th century, diabetes has been associated with
sexual dysfunction. Avicenna described this a “collapse
of sexual function” as a special complication of diabetes.
Diabetes causes significant changes on the various structures
and mechanisms of the male reproductive system through
endocrine disorders, neuropathy and increased oxidative
stress. Diabetic infertility has been shown to affect 15% of
couples, and diabetes is becoming an increasingly complicated
health problem worldwide. It is important to control blood
glucose levels in diabetes patients because damage is caused
by glucose toxicity due to hyperglycaemia [1,2].
DAPA is an insulin-independent antidiabetic drug
that acts as a SGLT2 inhibitor and aims to control

hyperglycaemia via providing glucose excretion from
the kidney through a mechanism different to that of
other antidiabetic drug groups. The major adverse effects
of SGLT2 inhibitors are hypoglycaemia, orthostatic
hypotension, dehydration, urinary tract infection and
genital infections caused by glycosuria. These infections
have been shown to progress to serious problems such
as acute kidney injury, urosepsis, pyelonephritis, bladder
cancer, vulvovaginitis and balanitis1. In addition, DAPA
has been associated with limb amputation, Fournier
gangrene, diabetic ketoacidosis, metabolic bone disease
and increased haematopoiesis [3]. Adverse effects related
to DAPA use are frequently updated and it is included in
the FDA’s watch list2.

Food and Drug Administration (FDA) (2013). Risk Assessment and risk mitigation review(s). Application number: 202293Orig1s000 [online]. Website
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/202293Orig1s000RiskR.pdf [accessed 15 December 2019].
1

Food and Drug Administration (FDA) (2017). New FDA watch list flags more drugs [online]. Website https://www.medscape.com/vewartcle/882425
[accessed 12 December 2019].
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As well as the genital infections caused by DAPA, its
use can lead to loss of libido and sexual motivation in men
[4,5]. The literature lacks sufficient information about
the effects of DAPA on the male reproductive system,
thus leading us to investigate these potential effects and
mechanisms in the case of repeated exposure.
2. Material and methods
2.1. Animals and study design
Twenty-one (10–12 weeks old) male SD rats (250–300 g)
were obtained from the experimental animal application
and research centre of Acıbadem University, Turkey. Four
or five animals were housed per standard polystyrene cage
and provided with food and water ad libitum. The rats
were maintained at 21–23 °C and humidity (55 ± 5%) in
a light-dark cycle in the Laboratory Animal Facility unit
of İstanbul University. Our experimental procedures
were approved by the İstanbul University Local Ethics
Committee for Experimental Animals (IUHADYEK
02.03.2018-2818/24) and all the work was carried out in
accordance with ethics committee principles. Following
the method of Furman (2015) with minor revisions, a
type 2 diabetes (T2DM) model was created with a highfat diet (35% fat, 26% protein and 26% carbohydrate) for
two weeks then application (i.p. injection; 35 mg/kg in 0.1
M citrate buffer, pH 4.5) of a single dose of STZ (SigmaAldrich, Saint Louis, MO, USA). Diabetes was verified by
measuring blood glucose levels from the tail blood of the
animals with a glucose analyser device (Vivacheck, Biotech
Inc., China). The animals with a nonfasting blood glucose
level >270 mg/dL were included in the experiment as the
diabetic group (n = 16) [6]. The diabetic animals were
randomly divided into two groups and diabetic control
(DC) (n = 8) and DAPA (n = 8) groups were formed.
While 10 mg of DAPA was administered to the DAPA
group for 28 days, the healthy control (C) and diabetic
control groups were given water and 0.5% methylcellulose
respectively by oral gavage.
The area under the plasma drug concentration-time
curve (AUC) at 10 mg/kg DAPA, which showed the
maximum glucose-lowering effect in SD rats, was 130fold greater than for humans at the same dose [7,8].
Accordingly, we used 10 mg/kg dose of DAPA in 0.5%
methylcellulose for the experiment.
On the 28th day, the rats were sacrificed by taking heart
blood under inhalation anaesthesia. Blood samples were
placed in EDTA-treated tubes for biochemical analysis.
The left testicle and epididymis were fixed in PBS (1X) for
biochemical analysis, and the right testicle and epididymis
were fixed in neutral buffered formalin (10%) and stored at
room temperature for histological studies.

2.2. Body and organ weights
The general condition of the animals, mortality and clinical
signs e.g., movements, posture, appearance and locomotor
activity were monitored daily, and body weight was
recorded 3 times a week throughout the study and on the
day of sacrification. The testicles were removed and weighed
immediately after sacrification. The somatic index was
calculated by dividing organ weight by body weight.
2.3. Sperm count and morphology
The epididymis was cleaned from the surrounding tissues
and cut into small pieces with scissors in 1 mL of DMEM-F12
medium with PBS to release sperm. The suspension was
centrifuged at 2230 rpm for 3 min. The supernatant (100
µL) was added to trypan blue (1:1, v/v). The mixture was
mounted on a Thoma slide and sperm was counted under
Leica microscope (Leica Microsystems Co., Wetzlar,
Germany) at 20X magnification.
To investigate sperm morphology, one drop of the
epididymis homogenate was spread on the slide. After
drying at room temperature, the slides were stained with
a Diff Quick staining kit (ADR, İstanbul, Turkey). Three
slides were prepared from each sample and 200 sperms were
evaluated from each slide. For morphological examination,
sperms were classified as normal, headless, flattened head,
pinhead, tailless, broken tail, broken neck and multiple
anomaly sperm3[9].
2.4. Biochemical and histological examination:
Blood samples in EDTA-treated tubes were centrifuged at
3000 rpm for 20 min and stored at –20 °C. The testicular tissues
in PBS (1:5, w/v) were stored at –80 °C, and homogenized on
ice at 4 °C on the day processed. Testosterone, GSH and MDA
levels were measured in plasma and tissue samples using
enzyme-linked immunosorbent assay (ELISA) commercial
kits (Elabscience, Wuhan, China; SunRed, Shanghai, China)
according to the manufacturer’s instructions.
Left testicles were fixed in a neutral buffered formalin
solution (10%) for 72 h then dehydrated by passing through
alcohol series and embedded in paraffin [10,11]. Thick
sections (4 µm) were taken from paraffin blocks and stained
with Haematoxylin and Eosin (H&E) for histopathological
semiquantitative analysis. The first seminiferous tubule was
randomly selected and others were selected in clockwise
fashion. Twenty seminiferous tubules were examined from
each section with the modified Johnson scoring method
(Table 1) [12] at 200X magnification. Seminiferous tubule
basement membranes were stained with periodic acid-Schiff
(PAS) dye for evaluation.
Endogenous peroxidase activity was suppressed by
immersion in hydrogen peroxide solution (3%). To ensure
antigen recovery, sections were exposed to microwave
treatment in heated citrate buffer (pH: 6) for 20 min. After

Industrial Reproductive Toxicology (IRDG) Computer Assisted Sperm Analysis (CASA) Group, 2000: Rat sperm morphological assessment guideline
document [online]. Website http://www.irdg.co.uk/Sperm_morphology.pdf [accessed 10 May 2019].
3
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washing with PBS, the slides were incubated overnight at
4 °C with the PCNA primary antibody (Thermo Scientific,
Massachusetts, USA). They were again washed with PBS
then stained with UltraTek HRP Anti-Polyvalent Staining
System (Scytek, Utah, USA) for 20 min according to
manufacturer’s protocol. Slides were washed with PBS,
3,3-diaminobenzidine tetrahydrochloride dihydrate
(DAB) (Abcam, Cambridge, UK) was applied and the
colour reaction was observed under the microscope. After
staining was checked, sections were counterstained with
Mayer haematoxylin (Millipore, Massachusetts, USA)
and mounted with entellan, then examined under a light
microscope. Twenty seminiferous tubules were examined
in tissue sections. The proliferation index was calculated
for each seminiferous tubule by dividing the number of
PCNA-positive cells by the total number of cells.
TUNEL assay was performed with ApopTag Plus
Peroxidase In Situ Apoptosis Kit (Millipore, Massachusetts,
USA) according to manufacturer’s protocol. Twenty
randomly selected seminiferous tubules were examined
from the tissue sections. The seminiferous tubules with
a TUNEL+ cell count of 3 or more were counted. The
apoptotic index was calculated by dividing the number of

seminiferous tubules containing 3 or more TUNEL+ cells
by the total number of seminiferous tubules.
2.5. Statistical analysis
Power analysis was performed with G*Power software
(version 3.1.9.7). The effect size of the study was 0.9804 (n
= 21). Results are given as values ± standard error of the
means (SEM). In statistical analysis, Statistical Package for
Social Sciences (SPSS, v.20, IBM Corporation, Armonk,
NY, USA) was used. The homogeneity of variances
was assessed using Levene’s test and the distribution of
normality was evaluated by the Shapiro–Wilk test (p >
0.05). Statistical significance of differences between groups
was validated with one-way analysis of variance (ANOVA)
followed by posthoc Tukey test for normally distributed
data. Kruskal–Wallis test was used for the data which are
not normally distributed. Values of p < 0.05 was considered
to be significant for all assays.
3. Results
Monitoring the animals daily, we observed a decrease in
movement and an increase in blood glucose levels, water
consumption, diuresis and fatigue in diabetic animals. The
mean weights of rats are given in Table 2. While normal

Table 1. Modified Johnson scoring method [15].

Score

Histological findings

10
9
8
7
6
5
4
3
2
1

Full spermatogenesis
Slightly impaired spermatogenesis, many late spermatids, disorganized epithelium
Less than five spermatozoa per tubule, few late spermatids
No spermatozoa, no late spermatids, many early spermatids
No spermatozoa, no late spermatids, few early spermatids
No spermatozoa or spermatids, many spermatocytes
No spermatozoa or spermatids, few spermatocytes
Spermatogonia only
No germinal cells, Sertoli cells only
No seminiferous epithelium
Table 2. Body weights on the 1st and 28th days testicular weights and testicular somatic index
of the rats.
C

DC

DAPA

Body weights (g), 1st day

355.84 ± 14.75

314.52 ± 10.25

318.1 ± 15.57

Body weights (g) 28th day

377.00 ± 15.18

296.85 ± 16.27*

330.55 ± 15.94

Testes weights (g)

1.507 ± 0.045

1.52 ± 0.025

1.612 ± 0.063

Somatic index (testis)

0.401 ± 0.011

0.514 ± 0.022*

0.491 ± 0.016*

Data were shown as mean ± SEM.
* significant difference compared to C group (p < 0.05).
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animals gained weight day by day, we observed weight loss
as a result of STZ application in diabetic animals. There
was a significant decrease in weights of the DC group
(1.84-fold) compared to the gains observed in group C (p:
0.020). While there was no difference between testicular
weights, there was a significant increase in the somatic
index values of diabetic groups compared to C (p ≤ 0.007).
We found a significant decrease in the sperm counts
of the DC and DAPA groups compared to the control (p <
0.002). After DAPA application, the sperm count decrease
associated with diabetes was less pronounced in the DAPA
group compared to the DC group (p < 0.001) (Table 3). The
number of sperms with anomalies increased by 25.12% in
the DC group, compared to the C group, and by 1.3-fold in
the DAPA group (p: 0.003). The number of anomaly sperms
showed a significant increase in the DAPA compared to
the DC group (0.9-fold) (p: 0.003). In DAPA, there was an
increase especially in detached head, bent tail, coiled tail
and multiple abnormalities-type morphological disorders.
As it can be seen in Table 4, while plasma and tissue
testosterone levels decreased in both diabetic groups, they
were higher in the DAPA group compared to the DC group.
Testicular testosterone levels decreased significantly in the

DC group (p: 0.002) compared to the C group, while there
was a significant increase in the DAPA compared to the
DC group (p: 0.006).
Similar to testosterone levels, plasma and testicular GSH
levels decreased in both diabetic groups, butwere higher
in the DAPA group than in DC group. Testicular GSH
levels decreased significantly in the DC group compared
to the C group (p: 0.009) and were significantly higher in
DAPA than in the DC group (p: 0.008). Compared to the
C group, the increase in plasma MDA levels in the diabetic
groups was statistically significant (p ≤ 0.046); however,
the increase was lower in the DAPA group (21.78%). This
significant difference in plasma results was not observed in
tissue MDA levels.
Group C exhibited normal testicular morphology with
regular spermatogenic cells and seminiferous tubules and
regular basement membrane (score 9.1). Spermatagonia,
primary and secondary spermatocytes, early spermatids
and spermatozoa were observed with regular morphology
in most seminiferous tubules. In DC group (score 6.7), a
large number of seminiferous tubules showed decreased
numbers of spermatogenic germ cells, large vacuole
formation between the cells and immature cell debris

Table 3. Sperm count and morphological examination results of animals.
Sperm count (×106/mL)

Sperm count

C

DC

DAPA

87.22 ± 6.65

26.69 ± 2.96*

61.35 ± 3.82*a

C

DC

DAPA

Sperm morphology (in 200 sperm) (mean ± SEM)
Normal sperm count (mean ± SEM)
Normal

179.7 ± 1.2

174.7 ± 3.7

154.2 ± 4.7*a

Sperm count with abnormalities (mean ± SEM)
Headless sperm

3.3 ± 0.6

5.3 ± 1.5

6.7 ± 1.0

Detached head

1.5 ± 0.7

4.7 ± 1.6*

8.8 ± 3.11*a

Flattened head

2.8 ± 0.7

1.3 ± 0.2

2.3 ± 0.6

Pinhead

1.0 ± 0.8

0.3 ± 0.2

0.5 ± 0.2

Bent neck

1.4 ± 0.3

2.8 ± 0.5

1.6 ± 0.3

Bent tail

6.3 ± 1.0

8.4 ± 1.3

14.7 ± 2.0*

Coiled tail

3.2 ± 0.8

1.6 ± 0.5

7.2 ± 1.5a

Multiple abnormalities

0.7 ± 0.3

0.9 ± 0.2

4.0 ± 1.0*

Total sperm count with abnormalities

20.3 ± 1.2

25.4 ± 3.7

47.5 ± 5.8*a

Percentage of the sperm with abnormalities (%)

9.9 ± 0.6

12.7 ± 1.8

23.8 ± 2.9*a

Percentage of the normal sperm (%)

89.9 ± 0.6

87.3 ± 1.8

77.1 ± 2.4

Data were shown as mean ± SEM.
*significant difference compared to C group (p < 0.05).
a
significant difference compared to DC group (p < 0.05).
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in the lumen. In addition, many seminiferous tubules
in this group had irregular and undulating basement
membrane structures. In the seminiferous tubules of
the DAPA group (score 7.3), we observed a considerable
reduction in the formation of large vacuoles between cells
and undulating basement membrane structure, as well
as increasing numbers of spermatogenic germ cells and
normal seminiferous tubules (Figures 1 and 2). There was
a significant decrease in seminiferous tubule scores in DC
and DAPA groups compared to C (p: 0.000). Similarly, the
DAPA group’s seminiferous tubule score was significantly
higher than DC group (p: 0.004) (Figure 1, Table 5).
PCNA+ cells were seen in the seminiferous tubules of all
groups (Figure 3). Compared to the C group, a significant
decrease was detected in the proliferation index of the DC
and DAPA groups (p ≤ 0.022). The proliferation index
decrease associated with diabetes was less pronounced in
the DAPA group compared to DC group (p < 0.001) (Table
5).

TUNEL+ cells were seen in the seminiferous tubules
of all groups (Figure 4). Apoptotic index values based
on TUNEL+ cell count, increased significantly in the DC
group (p: 0.004) compared to the C group, while there was
a significant decrease in the DAPA compared to the DC
group (p: 0.001) (Table 5).
4. Discussion
In order to investigate the male reproductive toxicity of
DAPA, STZ-induced diabetic male SD rats were orally
exposed to 10 mg/kg of DAPA once daily for 28 days. We
then evaluated the testicular weight; testicular somatic
index; plasma and testicular testosterone content; GSH and
MDA levels; sperm count; sperm morphology; TUNEL
apoptotic cell count and PCNA immunohistochemistry, as
well as the macroscopic, microscopic and histopathological
characteristics of testicular tissue.
The STZ-induced diabetes model has been reported to
cause significant weight loss in animals [13–16]. Similarly,

Table 4. Testosterone, GSH and MDA levels of animals in plasma and testes tissue.
Plasma levels (mean ± SEM)
C

DC

DAPA

Testosterone (ng/mL)

0.656 ± 0.033

0.593 ± 0.009

0.652 ± 0.019

GSH (µmol/mg protein)

0.054 ± 0.004

0.033 ± 0.003

0.052 ± 0.008

MDA (nmol/mg protein)

0.028 ± 0.005

0.101 ± 0.011*

0.079 ± 0.016*

Testosterone (ng/mL)

2.989 ± 0.259

2.042 ± 0.022*

2.633 ± 0.122a

GSH (µmol/mg protein)

0.093 ± 0.007

0.061 ± 0.005*

0.090 ± 0.007a

MDA (nmol/mg protein)

0.075 ± 0.008

0.115 ± 0.005

0.112 ± 0.015

Tissue levels (mean ± SEM)

Data were shown as mean ± SEM.
* significant difference compared to C group (p < 0.05).
a
significant difference compared to DC group (p < 0.05).

Figure 1. Histopathological imaging of the seminiferous tubules of experimental animals with H&E stain.
Representative photomicrographs of experimental groups. Normal testicular morphology with regular spermatogenic
cells and seminiferous tubules in group C; decrease in spermatogenic germ cell count in DC group (arrowhead), large
vacuole formation between cells (arrow), immature cell debris in the lumen (*); in the DAPA group, seminiferous
tubules with normal morphology (n) as well as seminiferous tubules in which large vacuole formations (arrow)
between cells are considerably reduced.
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Figure 2. Histopathological imaging of the seminiferous tubules of experimental animals with PAS staining.
Representative photomicrographs of experimental groups. Seminiferous tubules with regular and PAS-positive
basement membrane in group C; seminiferous tubules with irregular and undulating basement membrane (arrow)
structure and irregular PAS positive reaction in DC group; in the DAPA group, seminiferous tubules with a fairly
regular basement membrane structure showing positive reaction to PAS.
Table 5. Modified Johnson scoring, proliferation index and apoptotic index in the testes
tissue.
C

DC

DAPA

Seminiferous tubule score

9.05 ± 0.09

6.71 ± 0.15*

7.33 ± 0.11*a

Proliferation index

27.45 ± 0.58

20.36 ± 0.41*

25.58 ± 0.33* a

Apoptotic index (%)

3 ± 1.22

11.25 ± 1.57*

3.13 ± 1.32 a

Data were shown as mean ± SEM.
* significant difference compared to C group (p < 0.05).
a
significant difference compared to DC group (p < 0.05).

Figure 3. Imaging of the seminiferous tubules of experimental animals by PCNA immunohistochemistry.
Representative photomicrographs showing PCNA positive cells belonging to experimental groups. Multiple PCNA
positive cells in seminiferous tubules in group C (arrow); decreased PCNA positive cells (arrow) in the DC group,
increased PCNA positive cells (arrow) in the DAPA group.

we observed significant weight loss in the DC group that
received STZ compared to the C group (1.84-fold). The
body weight of the DAPA group was higher than the DC
group but not significantly so, and there was no notable
change in the weight of the DAPA group between the first
and last days in our study. The weight loss caused by STZ
may have been mitigated by the hyperphagia observed in
the DAPA group [7,16,17].
STZ-induced diabetes has been reported to cause a
decrease in testicular weights and testicular somatic index
[18,19]. In the present study, we observed no significant

difference in testicular weights of the diabetes groups
compared to the C group, corroborating the results of
Abbasi et al. [20]. However, the testicular somatic index
value increased significantly in DC and DAPA groups
compared to group C (≤ 22.44%). The increase might be
explained by the notable weight loss observed in those
animals [14,21].
Diabetes is known to affect spermatogenesis, decrease
sperm count and alter sperm morphology [14,18,22,23].
In this study, we observed a significant decrease in the
sperm count of diabetic groups compared to the C group
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Figure 4. TUNEL staining in seminiferous tubule tissue of experimental animals. Representative photomicrographs
showing TUNEL+ cells belonging to experimental groups. In group C, a small number of TUNEL+ cells (arrow) in
the seminiferous tubules, an increase in the number of seminiferous tubules containing 3 and more TUNEL+ cells in
the DC group, and a decrease in the number of seminiferous tubules containing 3 and more TUNEL+ cells (arrow)
in the DAPA group.

(≥ 29.66%). The DAPA group count was significantly
higher than DC group (1.3-fold), a result which could be
related to the antioxidant effect of DAPA [24,25].
Abnormal sperm count increased in both diabetic
groups, but the difference between the DC group and C
group was not significant. Similarly, some studies have
observed no significant difference between the sperm
morphologies of diabetic patients and healthy people
[26,27]. In the present study, the number of sperm with
impaired morphology was higher in the DAPA group
than the DC group. In other words, DAPA was observed
to cause damage to sperm morphology independent of
the effect of diabetes. While the improvements occurring
in all testicular and sperm parameters are thought to
result from antioxidant effects, deterioration in sperm
morphology suggests that the damage may be caused by
another mechanism. Similarly, Venkatesh et al. examined
the relationship between sperm morphology and oxidative
stress, and observed there is no correlation between them
[28]. Sperm formation and differentiation is a multistage
process in which many factors play a role, and further
studies are needed to understand how DAPA causes
morphological damage, and at which stage.
Studies have reported that diabetes generally affects
the male reproductive system through oxidative damage
and significant improvements have been achieved with
antioxidant therapy in many animal and clinical studies
[18,29]. Ding et al. reported that NO and reactive oxygen
species reduced fertilization rates and sperm quality,
causing damage to the testicle and resulting in apoptosis
and testicular atrophy [22]. Shrilatha [23] found that
diabetes caused oxidative damage and raised MDA levels
in the testes of diabetic mice, leading to increased levels
of testicular GSH and other enzymes (PK, GSH-Px, GST
and SOD) that result from oxidative damage. Similarly,
plasma and testicular GSH levels decreased while MDA
levels increased in diabetic groups in our study. Compared
to the C group, the decrease in testicular GSH levels of the
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DC group (34.4%) and the increase in plasma MDA levels
of the DC and DAPA group (≥ 1.82-fold) were found to be
statistically significant. In the DAPA group, testicular GSH
depletion was lower (47.54%), compared to DC group.
The results may be due to the antioxidant effect of DAPA
[24,25].
Diabetes is known to disturb the secretion of many
hormones effective in the male reproductive system.
Insulin has a stimulating effect on testosterone production
and a decrease in testosterone levels is observed in its
deficiency [23,30,31]. Decreased testosterone levels have
been reported in STZ-induced diabetic animals [14,22].
In our study, as with other oxidation-affected parameters,
testicular testosterone levels decreased significantly in DC
group compared to the control (31.68%), whereas there
was a significant increase in testosterone in the DAPA
group compared to the DC group (28.94%). Although a
similar situation was observed in plasma testosterone
levels, the differences were not statistically significant.
Diabetes also causes histological damage, including
decreased germ cell count, atrophy of seminiferous
tubules, disruption of seminiferous tubules and cells, and
accumulation of immature and irregular cells in the cell
lumen [14,18,19]. Contrary to other studies, NavarroCasado et al. reported no change in testicular histology
associated with STZ-induced diabetes in 45 and 60 mg/
kg single doses [31]. Similar to the studies mentioned
above, our work observed a decrease in the number
of spermatogenic germ cells, large vacuole formation
between cells and immature cell debris in the lumen of
many seminiferous tubules in DC and DAPA groups,
compared to the C group. In the DAPA group, large vacuole
formation between cells in the seminiferous tubules
decreased significantly, while numbers of spermatogenic
germ cells and normal seminiferous tubules increased,
compared to the DC group.
Diabetes is known to promote apoptotic death
and inhibit cell proliferation in germ cells such as

ULUS KARACA et al. / Turk J Med Sci
spermatogonia and spermatocytes [21,32-34]. In parallel
with the existing literature, we observed that apoptotic
cells increased among the spermatogonia and primary
spermatocytes of diabetic groups. The DAPA group, on the
other hand, saw significantly lower rates of apoptotic death
and apoptotic index alongside increased cell proliferation
and proliferation index.
In conclusion, the formation of diabetes in animals
leads to the induction of apoptosis and oxidative
damage in the seminiferous tubules, while damage to
the reproductive system occurs through an observable
change in testicular tissue and sperm parameters. The
damage was less pronounced in diabetic animals treated
with DAPA, which had results similar to the control in all

areas investigated except for sperm damage. It is thought
that the improvements may be due to the glucose lowering
or antioxidant effects of DAPA. However, DAPA caused
to increase the number of morphologically damaged
sperm, and further studies are needed to understand the
underlying mechanism for sperm damage. The present
work is the first to study the effects of DAPA on the male
reproductive system. DAPA-induced healthy animal group
could not be evaluated because there was no approval in
ethical committee, which is the limitation of the study.
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